|10.5 0.09 (0.86%)||11-02 16:00|
|Targets||6-month :||12.26||1-year :||14.32|
|Resists||First :||10.5||Second :||12.26|
|Supports||First :||10.41||Second :||10.35|
|MAs||MA(5) :||10.48||MA(20) :||10.41|
|MA(100) :||9.52||MA(250) :||7.02|
|MACD||MACD :||0||Signal :||0|
|%K %D||K(14,3) :||100||D(3) :||94.4|
|52-week||High :||10.5||Low :||3.15|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TRHC ] has closed below upper band by 10.1%. Bollinger Bands are 84.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 51 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||10.52 - 10.58||10.58 - 10.62|
|Low:||10.35 - 10.43||10.43 - 10.48|
|Close:||10.4 - 10.51||10.51 - 10.6|
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Thu, 02 Nov 2023
Tabula Rasa to go private after $570M acquisition - NJBIZ
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Health Information Services
|Shares Out||27 (M)|
|Shares Float||18 (M)|
|Held by Insiders||12.1 (%)|
|Held by Institutions||70.6 (%)|
|Shares Short||733 (K)|
|Shares Short P.Month||737 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||-3.05|
|Profit Margin||-28.3 %|
|Operating Margin||-6.4 %|
|Return on Assets (ttm)||-6 %|
|Return on Equity (ttm)||0 %|
|Qtrly Rev. Growth||24 %|
|Gross Profit (p.s.)||2.47|
|Sales Per Share||12.49|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||-5 (M)|
|Levered Free Cash Flow||147 (M)|
|Price to Book value||-3.45|
|Price to Sales||0.84|
|Price to Cash Flow||-55.37|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|